Despite the limited value of CEA for CRC screening, as elevated CEA levels may be due to some non-malignant diseases such as chronic inflammatory bowel disease, pancreatitis, and liver disease [32], substantial evidence has confirmed its predictive ability in the recurrence, metastasis, and survival of CRC patients. This evidence concerns the gene CEACAM5 and colorectal carcinoma.